- Atomoxetine (Strattera®)
- Citalopram (Celexa®)
- Coenzyme Q-10 - PREQUEL
- Creatine - PRECREST
- Ethyl-EPA (Miraxion)
- Memantine (Namenda®)
- Minocycline (Minocin®)
- Tetrabenazine (Nitoman®, Xenazine®)
Clinical Trial Background by Huntington Study Group (HSG)
Clinical Trial Background by NIH ClinicalTrials.gov
List of Clinical Trials by NIH ClinicalTrials.gov
Trial information at NIH ClincalTrials.gov
Trial status: Completed
Trial name: DOMINO
FDA phase: Phase II futility trial. A futility trial is designed to test a minimal level of benefit necessary to proceed to a phase III clinical trial.
Trial results: Minocycline showed no benefit over placebo in any tested measure.